Yamanouchi Pharmaceutical Co., Ltd. And Fujisawa Pharmaceutical Co., Ltd. Unite To Form Astellas Pharma Inc., North American Headquarters To Be In Chicago
10/19/2005 5:13:11 PM
More...
|
Japanese Drugmakers Strengthen Area Ties
10/19/2005 5:13:10 PM
More...
|
Yamanouchi Pharmaceutical Co., Ltd. , Keio University Discover Target Molecule For Anti-obesity And Antidiabetic Drug
10/19/2005 5:13:07 PM
More...
|
Fujisawa Healthcare, Inc. Release: Mycamine(TM) Receives FDA Approval
10/19/2005 5:13:03 PM
More...
|
Icagen, Inc. (ICGN) Receives Milestone Payment From Yamanouchi Pharmaceutical Co., Ltd.
10/19/2005 5:13:00 PM
More...
|
Merger Mania Besets Japanese Pharmaceuticals
10/19/2005 5:12:49 PM
More...
|
Yamanouchi Pharmaceutical Co., Ltd. Terminates Marketing Agreement With Daiichi Suntory Pharma Co., Ltd.
10/19/2005 5:12:46 PM
More...
|
Yamanouchi Pharmaceutical Co., Ltd. To License Gelpart Coronary Embolism Material To Nippon Kayaku Co., Ltd.
10/19/2005 5:12:39 PM
More...
|
Yamanouchi Pharmaceutical Co., Ltd. To Transfer All Sanwell Shares To Asahi Breweries
10/19/2005 5:12:36 PM
More...
|
Lipitor, Atorvastatin Calcium Hydrate Greatly Inhibits Coronary Artery Plaque Progression: Yamanouchi Pharmaceutical Co., Ltd., Pfizer Japan
10/19/2005 5:12:35 PM
More...
|
|